Twitxy Saved

dough

Verified account This account is verified. Learn more

@semodough

BIOTECH man LONGTERM FOCUS many positions-also trade around my CORE holdings my opinion only do your own research with me
Joined September 2015
653 Following 45K Followers 83K Posts

Latest posts 5

Pinned post

dough Verified account @semodough
Wonderful Day for me. - celebrating 25 GREAT years with my WIFE & best friend today. Best decision I ever made - happy #anniversary to my WIFE ❤️❤️
dough Verified account @semodough Oct 14, 2017
Tomorrow 23 year anniversary +8 years of dating -like @SheffStation I started young 😃 MY WIFE best #LONGTERM Decisions I ever made ❤️❤️❤️ x.com/tgtxdough/stat…
View quoted post on X
dough Verified account @semodough
$VIR slides for tomorrow?? s203.q4cdn.com/628578897/file…
dough Verified account @semodough 4h
$VIR •Data presented at AASLD The Liver Meeting demonstrated 100% of participants (28/28) who completed Week 96 of combination therapy reached undetectable virus (as defined by HDV RNA TND)
•Separate, exploratory analysis suggests curative potential with 10/10 patients who discontinued treatment after at least 96 weeks of undetectable virus showing sustained viral response (SVR) after 12 to 48 weeks of follow-up
•Conference call to discuss topline ECLIPSE 1 results and expanded SOLSTICE data scheduled for November 9, 2026, at 8:30 a.m. ET / 5:30 a.m. PT
View quoted post on X
0 replies 1 reposts 8 likes 2.9K views View on X
dough Verified account @semodough
$VIR - I be surprised if $GILD not watching closely •Separate, exploratory analysis suggests curative potential with 10/10 patients who discontinued treatment after at least 96 weeks of undetectable virus showing sustained viral response (SVR) after 12 to 48 weeks of follow-up
dough Verified account @semodough 4h
$VIR •Data presented at AASLD The Liver Meeting demonstrated 100% of participants (28/28) who completed Week 96 of combination therapy reached undetectable virus (as defined by HDV RNA TND)
•Separate, exploratory analysis suggests curative potential with 10/10 patients who discontinued treatment after at least 96 weeks of undetectable virus showing sustained viral response (SVR) after 12 to 48 weeks of follow-up
•Conference call to discuss topline ECLIPSE 1 results and expanded SOLSTICE data scheduled for November 9, 2026, at 8:30 a.m. ET / 5:30 a.m. PT
View quoted post on X
0 replies 0 reposts 5 likes 2.5K views View on X
dough Verified account @semodough
$VIR •Data presented at AASLD The Liver Meeting demonstrated 100% of participants (28/28) who completed Week 96 of combination therapy reached undetectable virus (as defined by HDV RNA TND)
•Separate, exploratory analysis suggests curative potential with 10/10 patients who discontinued treatment after at least 96 weeks of undetectable virus showing sustained viral response (SVR) after 12 to 48 weeks of follow-up
•Conference call to discuss topline ECLIPSE 1 results and expanded SOLSTICE data scheduled for November 9, 2026, at 8:30 a.m. ET / 5:30 a.m. PT
dough Verified account @semodough 4h
$VIR Vir Biotechnology, Inc. - Vir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data investors.vir.bio/news/news-deta…
View quoted post on X
0 replies 2 reposts 6 likes 4.9K views View on X
dough Verified account @semodough
$VIR Vir Biotechnology, Inc. - Vir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data investors.vir.bio/news/news-deta…
investors.vir.bio Vir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic... Data presented at AASLD The Liver Meeting demonstrated 100% of participants (28/28) who completed Week 96 of combination therapy reached undetectable virus (as defined by HDV RNA TND) Separate,...